Home Page News Statistics API Remark API Price Formulation Market report Im&Ex report Free Information All Information
Keyword:
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
　　Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Conference on industry studie...
Information Release Conference&nbs...
Internationalization forum of ...
Welcome to Proseminar on ...
Healthoo.com Carbapenems forcum&nb...
APIs Innovation Forum will&nb...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Company
NHU Vitamin E project passed acceptance check2020-02-27
HEC to build Oseltamivir phosphate project2020-02-27
Yishunying got D-Calcium feed additive production license2020-02-25
Aobang to build the project of anti-influenza APIs2020-02-25
Costar resumed Nicotinamide production2020-02-25
NHU resumed normal production2020-02-20
Tongji resumed Metronidazole production2020-02-19
Synergy Celecoxib passed Japan PMDA2020-02-19
Lingsheng 7-ANCA reached the designed capacity2020-02-19
FDA cautions Aurobindo oral solids formulation facility2020-02-19
Wild Wind Methyldopa sales value increased in 20192020-02-19
Conba produces Vitamin B2 with full load2020-02-18
Yitai resumed Ribavirin production2020-02-18
Guangji Vitamin B2 supply sufficient2020-02-13
Tianli to build Vitamin C project2020-02-12
Vertellus got Nicotinamide feed production license2020-02-12
Conba Spectinomycin passed FDA on-site inspection2020-01-31
Dawnrays to build Cephalosporin project2020-01-22
Yinfeng Choline chloride sale obviously increasing2020-01-21
NHU got Coenzyme Q10 drug manufacturing certificate2020-01-20
Tiger to build Calcium Pantothenate project2020-01-20
Jincheng to build Cefuroxime project2020-01-17
Huaxin is building Sulbactam project2020-01-17
Anzhou to build Quinolone API project2020-01-17
Xinrui Valsartan passed environmental acceptance2020-01-15
Hisun Atorvastatin calcium passed environmental acceptance2020-01-15
Tonghe to build Metformin Lipoic acid project2020-01-15
Zhebang Cefalexin project passed environmental acceptance2020-01-14
Ouyi to build APIs project2020-01-14
Tianli Anhydrous Glucose Mannitol approved2020-01-13
Hengshun 7-ACA project passed environmental acceptance2020-01-13
Shenghelong to build Paroxetine Levetiracetam project2020-01-09
共2272个 页次:3/71页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463